ĐẶC ĐIỂM SINH HỌC CỦA BIẾN CHỦNG Streptomyces orientalis 4912-81-61 SINH VANCOMYCIN

Chu Thanh Bình1, Lê Gia Hy2, Nguyễn Phương Nhuệ2
1 Trung tâm Nhiệt đới Việt - Nga
2 Viện Công nghệ sinh học, Viện Khoa học và Công nghệ Việt Nam

Nội dung chính của bài viết

Tóm tắt

BIOLOGICAL CHARACTERISTICS OF MUTANT STRAIN Streptomyces orientalis 4912-81-61 PRODUCING VANCOMYCIN

Vancomycin, which is produced by Streptomyces orientalis, is an antibiotic used in clinical treatment against pathogens resistant to many popular antibacterial agents. The mutant strain Streptomyces orientalis 4912-81-61 producing high yeild of vancomycin was obtained as the result of N-methyl-N’-nitro-N-nitrosoguanidine treatment on the protoplasts of original strain S. orientalis 4912. In the present work, the mutant strain Streptomyces orientalis 4912-81 61 was studied with respect to the biological characteristics. Antibiotic production of this mutant strain was enhanced by 94,3% compared to the original strain. The antibiotic produced by this mutant strain was determined as vancomycin with a anti-microbial spectrum, inhibiting tested strains of genera BacillusStaphylococcus and Escherichia. This mutant strain grow at favourable conditions such as pH range of 6-8, temperature of 28-30oC, in medium containing NaCl concentration not more than 6%. The strain S. orientalis 4912-81-61 express enzyme activities to degrade casein, gelatin and starch. The fermentation process producing vancomycin by the mutant strain S. orientalis 4912- 81-61 should be performed more convenient as its abilities of enzyme productivity and utilization of different sugars.

Chi tiết bài viết

Tài liệu tham khảo

1. Nguyễn Phương Nhuệ, Chu Thanh Bình, Lê Gia Hy, “Nâng cao khả năng sinh chất kháng sinh vancomycin của chủng Streptomyces orientalis 4912 bằng gây đột biến tế bào trần”, Tạp chí Khoa học và Công nghệ, 50, 3B, tr.150 - 157.
2. Egorov N.X. (Nguyễn Lân Dũng dịch), 1976, Thực tập vi sinh vật học, Nhà xuất bản Khoa học và Kỹ thuật, Hà Nội.
3. Hopwood D.A., Bibb M.J., Chater K.F., Kieser T., Bruston C.J., Kieser H.M., Lydiate D.J., Smith C.P. and Ward J.M., 1985, “Genetic manipulation of Streptomyces”, A laboratory manual, F.Crowe & Sons, Norwich, England, p.35-41.
4. Jung H.M., Kim S.Y., Moon H.J., Oh D.K. and Lee J.K., 2007, “Optimization of culture conditions and scale-up to pilot and plant scale for vancomycin production by Amycolatopsis orientalis”, Applied Microbiology Biotechnology, 77, p.789-795.
5. KCTC Strain Database, http://kctc.kribb.re.kr/intranet
6. Sussmuth R.D., 2006, “The chemistry and biology of vancomycin and other glycopeptide antibiotic derivatives”, In: Liang X.T., Fang W.S., eds, Medicinal chemistry of bioactive natural products, John Wiley & Sons, Inc., New Jersey, p.35-52.
7. Shirling E.G., Gottlieb D., 1966, “Methods for characterization of Streptomyces species”, Int J Syst Bacteriol, 16, p.313-340.
8. Stanley T., Williams M.E., Sharpe and J.G., Holt, 1989, Bergey’s Mannual of Systematic bacteriology, Williams & Wilkins, 4, p.2452-2492.
9. Kim S.Y., Kim D.S., Jung H.M., Lee J.K., 2008, “Mutant strain of Amycolaptosis orientalis and process for preparing vancomycin hydrochloride”, European patent application EP 1959006A1.